Terms: = Gastric cancer AND AFF3, MLLT2-like, 3899, ENSG00000144218, LAF4, P51826
5 results:
1. aff3 is a novel prognostic biomarker and a potential target for immunotherapy in gastric cancer.
Zeng Y; Zhang X; Li F; Wang Y; Wei M
J Clin Lab Anal; 2022 Jun; 36(6):e24437. PubMed ID: 35478418
[TBL] [Abstract] [Full Text] [Related]
2. FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review).
Katoh M
Int J Mol Med; 2016 Jul; 38(1):3-15. PubMed ID: 27245147
[TBL] [Abstract] [Full Text] [Related]
3. Genome-wide analysis of histone H3 lysine 27 trimethylation by ChIP-chip in gastric cancer patients.
Zhang L; Zhong K; Dai Y; Zhou H
J Gastroenterol; 2009; 44(4):305-12. PubMed ID: 19267258
[TBL] [Abstract] [Full Text] [Related]
4. [Protein profiles of serum in gastric cancer at a high-risk area by SELDI-TOF mass spectrometry].
Wang YS; Shen J; Yu JK; Zhang L; Ma JL; You WC; Pan KF
Zhonghua Yu Fang Yi Xue Za Zhi; 2008 Sep; 42(9):677-80. PubMed ID: 19175180
[TBL] [Abstract] [Full Text] [Related]
5. Transcription of human ABO histo-blood group genes is dependent upon binding of transcription factor CBF/NF-Y to minisatellite sequence.
Kominato Y; Tsuchiya T; Hata N; Takizawa H; Yamamoto F
J Biol Chem; 1997 Oct; 272(41):25890-8. PubMed ID: 9325321
[TBL] [Abstract] [Full Text] [Related]
